IPIX .. notice of effectiveness filed News New
Post# of 72440
(Total Views: 367)
Posted On: 10/22/2019 7:47:17 AM
IPIX .. notice of effectiveness filed
The notice of effectiveness is a public declaration by the Securities and Exchange Commission that a public company's registration statement has been accepted. For shares in a public company to trade on the open market they must be registered by the company.
https://www.sec.gov/cgi-bin/browse-edgar?acti...333-220419
http://www.ipharminc.com/financials
==============
IPIX Filing AH/s
http://www.ipharminc.com/financials
EXPLANATORY NOTE
On September 11, 2017, the registrant filed with the Securities and Exchange Commission (the “SEC”) a Registration Statement on Form S-3 (No. 333-220419), which was declared effective by the SEC on September 21, 2017 (the “Original Registration Statement”). The Original Registration Statement was filed to register shares of the registrant’s Class A common stock, preferred stock, debt securities, warrants and units, including shares of Class A common stock or preferred stock upon conversion of debt securities, Class A common stock upon the conversion of preferred stock, or Class A common stock, preferred stock or debt securities upon the exercise of warrants. In connection with the Original Registration Statement, the registrant offered and sold shares of Series B preferred stock, which shares are convertible into shares of Class A common stock, and warrants to purchase shares of Series B preferred stock pursuant to prospectus supplements filed with the U.S. Securities and Exchange Commission on October 9, 2018 and May 10, 2019.
Following the filing of the registrant’s Annual Report on Form 10-K for the fiscal year ended June 30, 2019, the registrant is no longer eligible to offer securities on Form S-3. This Post-Effective Amendment No. 2 to Form S-3 on Form S-1 is being filed to convert the Original Registration Statement into a Registration Statement on Form S-1, and contains an updated prospectus relating to the offering and sale of the shares of Series B preferred stock and Class A common stock that were registered on the Original Registration Statement.
All applicable registration and filing fees were paid by the registrant in connection with filing the Original Registration Statement.
========================
so Innovation's 10K was filed on 9.30.19
========================
prior post effective amendment filed on 9.20.19
EXPLANATORY NOTE
On September 11, 2017, the registrant filed with the Securities and Exchange Commission (the “SEC”) a Registration Statement on Form S-3 (No. 333-220419), which was declared effective by the SEC on September 21, 2017 (the “Original Registration Statement”). The Original Registration Statement was filed to register shares of the registrant’s Class A common stock, preferred stock, debt securities, warrants and units, including shares of Class A common stock or preferred stock upon conversion of debt securities, Class A common stock upon the conversion of preferred stock, or Class A common stock, preferred stock or debt securities upon the exercise of warrants. In connection with the Original Registration Statement, the registrant offered and sold shares of Series B preferred stock, which shares are convertible into shares of Class A common stock, and warrants to purchase shares of Series B preferred stock or Class A common stock pursuant to prospectus supplements filed with the U.S. Securities and Exchange Commission on October 9, 2018 and May 10, 2019.
This Post-Effective Amendment No. 1 to Form S-3 on Form S-1 is being filed to convert the Original Registration Statement into a Registration Statement on Form S-1, and contains an updated prospectus relating to the offering and sale of the shares of Series B preferred stock and Class A common stock that were registered on the Original Registration Statement.
All applicable registration and filing fees were paid by the registrant in connection with filing the Original Registration Statement.
=================
courtesy of investopedia
https://www.investopedia.com/terms/s/sec-pos-am-filing.asp
BREAKING DOWN SEC POS AM Filing
SEC POS AM is a filing that has post-effective amendments to provide updated prospectus information. A prospectus is a formal legal document that is required by and filed with the SEC that provides details about an investment offering for sale to the public. The preliminary prospectus is the first offering document provided by a security issuer and includes most of the details of the business and transaction in question.
The final prospectus, containing background information including such details as the exact number of shares/certificates issued and the precise offering price, is printed after the deal has been made effective. In the case of mutual funds, a fund prospectus contains details on its objectives, investment strategies, risks, performance, distribution policy, fees and expenses, and fund management.
Read More: https://investorshangout.com/post/newpost/873...z635BIdYSi
News News Alert: Notice of Effectiveness (effect) 10/22/2019 06:01:03 AM
The notice of effectiveness is a public declaration by the Securities and Exchange Commission that a public company's registration statement has been accepted. For shares in a public company to trade on the open market they must be registered by the company.
https://www.sec.gov/cgi-bin/browse-edgar?acti...333-220419
http://www.ipharminc.com/financials
==============
IPIX Filing AH/s
News News Alert: Post-effective Amendment to Registration Statement (pos Am) 10/17/2019 05:24:36 PM
http://www.ipharminc.com/financials
EXPLANATORY NOTE
On September 11, 2017, the registrant filed with the Securities and Exchange Commission (the “SEC”) a Registration Statement on Form S-3 (No. 333-220419), which was declared effective by the SEC on September 21, 2017 (the “Original Registration Statement”). The Original Registration Statement was filed to register shares of the registrant’s Class A common stock, preferred stock, debt securities, warrants and units, including shares of Class A common stock or preferred stock upon conversion of debt securities, Class A common stock upon the conversion of preferred stock, or Class A common stock, preferred stock or debt securities upon the exercise of warrants. In connection with the Original Registration Statement, the registrant offered and sold shares of Series B preferred stock, which shares are convertible into shares of Class A common stock, and warrants to purchase shares of Series B preferred stock pursuant to prospectus supplements filed with the U.S. Securities and Exchange Commission on October 9, 2018 and May 10, 2019.
Following the filing of the registrant’s Annual Report on Form 10-K for the fiscal year ended June 30, 2019, the registrant is no longer eligible to offer securities on Form S-3. This Post-Effective Amendment No. 2 to Form S-3 on Form S-1 is being filed to convert the Original Registration Statement into a Registration Statement on Form S-1, and contains an updated prospectus relating to the offering and sale of the shares of Series B preferred stock and Class A common stock that were registered on the Original Registration Statement.
All applicable registration and filing fees were paid by the registrant in connection with filing the Original Registration Statement.
========================
so Innovation's 10K was filed on 9.30.19
========================
prior post effective amendment filed on 9.20.19
EXPLANATORY NOTE
On September 11, 2017, the registrant filed with the Securities and Exchange Commission (the “SEC”) a Registration Statement on Form S-3 (No. 333-220419), which was declared effective by the SEC on September 21, 2017 (the “Original Registration Statement”). The Original Registration Statement was filed to register shares of the registrant’s Class A common stock, preferred stock, debt securities, warrants and units, including shares of Class A common stock or preferred stock upon conversion of debt securities, Class A common stock upon the conversion of preferred stock, or Class A common stock, preferred stock or debt securities upon the exercise of warrants. In connection with the Original Registration Statement, the registrant offered and sold shares of Series B preferred stock, which shares are convertible into shares of Class A common stock, and warrants to purchase shares of Series B preferred stock or Class A common stock pursuant to prospectus supplements filed with the U.S. Securities and Exchange Commission on October 9, 2018 and May 10, 2019.
This Post-Effective Amendment No. 1 to Form S-3 on Form S-1 is being filed to convert the Original Registration Statement into a Registration Statement on Form S-1, and contains an updated prospectus relating to the offering and sale of the shares of Series B preferred stock and Class A common stock that were registered on the Original Registration Statement.
All applicable registration and filing fees were paid by the registrant in connection with filing the Original Registration Statement.
=================
courtesy of investopedia
https://www.investopedia.com/terms/s/sec-pos-am-filing.asp
BREAKING DOWN SEC POS AM Filing
SEC POS AM is a filing that has post-effective amendments to provide updated prospectus information. A prospectus is a formal legal document that is required by and filed with the SEC that provides details about an investment offering for sale to the public. The preliminary prospectus is the first offering document provided by a security issuer and includes most of the details of the business and transaction in question.
The final prospectus, containing background information including such details as the exact number of shares/certificates issued and the precise offering price, is printed after the deal has been made effective. In the case of mutual funds, a fund prospectus contains details on its objectives, investment strategies, risks, performance, distribution policy, fees and expenses, and fund management.
Read More: https://investorshangout.com/post/newpost/873...z635BIdYSi
(3)
(1)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼